Login
Runway Growth Finance Corp logo

Runway Growth Finance Corp

investors.runwaygrowth.com

Runway Growth Finance Corp (NASDAQ: RWAY) is a specialty finance company that provides senior secured loans to high-growth-potential companies in technology, healthcare, business services, financial services, and select consumer services and products. Revenue comes primarily from interest income on these senior secured debt investments, structured with floating-rate spreads over SOFR or Prime, plus end-of-term payments (ETP) and, in some cases, payment-in-kind (PIK) interest components. The company also receives warrants and equity co-investments alongside its debt positions, giving it upside participation in borrower exits. RWAY is structured as an externally managed, non-diversified closed-end management investment company under the Investment Company Act of 1940, incorporated in Maryland and formed on August 31, 2015. Its target borrowers are venture capital-backed companies that cannot access conventional bank financing because traditional lenders underwrite to tangible asset values or operating cash flow, segments where RWAY faces limited direct competition due to high barriers to entry in venture lending.

Products & Services

Senior secured term loans, revolving credit facilities, second lien loans, bridge loans, and warrant or equity co-investments to venture capital-backed growth companies across technology, healthcare, business services, financial services, and select consumer sectors.

Revenue Model

Interest income on senior secured floating-rate loans (SOFR-based or Prime-based spreads with floors), end-of-term payments, PIK interest, and gains from warrant and equity investments held alongside debt positions.

Customers & Markets

Venture capital-backed, high-growth-potential companies in application software, systems software, healthcare technology, pharmaceuticals and biotechnology, commercial and professional services, consumer services, consumer staples distribution, media and entertainment, property and casualty insurance, and technology hardware. Borrowers are typically unable to obtain financing from commercial banks due to limited tangible assets or negative operating cash flow.

Geographic Exposure

Primarily United States-based portfolio companies, with select international borrowers including Marley Spoon SE and FINN GmbH, and Shield Therapeutics PLC, as disclosed in the FY2025 10-K filed 2026-03-12.

Financial Snapshot

Revenue
TTM
$60.22M
Gross Margin
TTM
713.57%
Net Income
TTM
-$2.634M
Current Assets
2026 Q1
$2.312M
Current Liabilities
2026 Q1
$24.82M
Current Ratio
2026 Q1
9.32%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
438.2M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $231.86 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support